Alphatec HoldingsATEC +2.43%66 3-Year ROIIC % is 38.24 as of Dec. 2025. GuruFocus rates ATEC with a GF Score™ of 66/100 and a GF Value™ of $15.32 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Alphatec Holdings ranks better than 80.35% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Alphatec Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 38.24%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Alphatec Holdings's 3-Year ROIIC % or its related term are showing as below:
ATEC's 3-Year ROIIC % is ranked better than 80.35% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs ATEC: 38.24
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Alphatec Holdings 3-Year ROIIC % Related Terms
Alphatec Holdings 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Alphatec Holdings's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATEC vs IART, AHCO, INSP: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Alphatec Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alphatec Holdings 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Alphatec Holdings's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Alphatec Holdings (ATEC) has a 3-Year ROIIC % of 38.24 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Alphatec Holdings and its competitors. According to the industry distribution chart, Alphatec Holdings ranks #157 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 19.6%.
Is Alphatec Holdings' 3-Year ROIIC % too high?
Alphatec Holdings' current 3-Year ROIIC % is 38.24. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. Alphatec Holdings' value of 38.24 is 2501.4% above this industry median. Based on the distribution chart, Alphatec Holdings ranks #157 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Alphatec Holdings has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Alphatec Holdings' 3-Year ROIIC % compare to IART and AHCO?
According to the Medical Devices & Instruments industry distribution chart, Alphatec Holdings ranks #157 out of 799 companies for 3-Year ROIIC %. This places Alphatec Holdings in the top 20% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.47. Alphatec Holdings' value of 38.24 is 2501.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alphatec Holdings's current 3-Year ROIIC % of 38.24 is 2501.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Alphatec Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alphatec Holdings's current 3-Year ROIIC % is 38.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alphatec Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alphatec Holdings (ATEC) is currently considered Possible Value Trap. The stock's GF Value™ is $15.32, compared to a current price of $8.86 — trading 42.2% below its estimated fair value. The current 3-Year ROIIC % is 38.24 and 2501.4% above the Medical Devices & Instruments industry median of 1.47. Alphatec Holdings' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Alphatec Holdings (ATEC), the current 3-Year ROIIC % is 38.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alphatec Holdings (ATEC) Overvalued in 2026?
Based on GuruFocus' analysis, Alphatec Holdings stock appears to be undervalued.
The current stock price of $8.86 is trading 42.2% below its estimated GF Value™ of $15.32.
GuruFocus considers Alphatec Holdings to be Possible Value Trap.
Key valuation signals for ATEC:
3-Year ROIIC %: 38.24
GF Value™: $15.32 vs. price of $8.86 (42.2% below fair value)
Industry Position: 2501.4% above the Medical Devices & Instruments median (#157 of 799)
No single metric tells the full story. See the ATEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
66GF Score
Get the complete analysis for ATEC
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATEC has been successfully added to your 
